Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2008
11/20/2008WO2008139703A1 Agent for treatment of pulmonary disease
11/20/2008WO2008139637A1 Pharmaceutical preparation and manufacturing method thereof
11/20/2008WO2008139575A1 Preparation for oral administration
11/20/2008WO2008139467A2 Lipid conjugated cyclic carbonate derivatives, their synthesis, and uses
11/20/2008WO2008139457A2 Ph-dependent drug targeting
11/20/2008WO2008139313A2 Propofol transparent anaesthetic solution with low venous irritation
11/20/2008WO2008139264A2 Soft gel formulations
11/20/2008WO2008139229A2 Pores
11/20/2008WO2008139207A2 Labelled hgf binding peptides for imaging
11/20/2008WO2008138459A2 Aqueous pharmaceutical preparation
11/20/2008WO2008138139A1 Carbohydrate-containing pan cancer marker
11/20/2008WO2008138089A2 Pharmaceutical composition comprising a local anaesthetic and a carboxyvinyl polymer
11/20/2008WO2008121422A3 Implantable cell matrix composition for delivery of bioactive compounds
11/20/2008WO2008118752A3 Shortened purification process for the production of capsular streptococcus pneumoniae polysaccharides
11/20/2008WO2008112277A3 Compositions and methods for treating cancer
11/20/2008WO2008103847A3 Bridged polycyclic compound based compositions for the inhibition and amelioration of disease
11/20/2008WO2008098693A3 Convergent synthesis of glp-1
11/20/2008WO2008097922A3 Golden mean harmonized water and aqueous solutions
11/20/2008WO2008095479A3 Use of a highly emulsified silicone oil (hes) for the production of a medicament
11/20/2008WO2008092084A3 Injectable non-aqueous suspension with high concentration of therapeutic agent
11/20/2008WO2008088658A3 Polymeric carriers of therapeutic agents and recognition moieties for antibody-based targeting of disease sites
11/20/2008WO2008085199A3 Conducting polymer nanotube actuators for precisely controlled release of medicine and bioactive molecules
11/20/2008WO2008078102A3 Lipids and their use as non-viral delivery vehicle
11/20/2008WO2008077956A3 Oligonucleotide-, protein and/or peptide-polymer conjugates
11/20/2008WO2008062453B1 Composition containing nicotine base aromatic oils and alkyl salicylate for the delivery of nicotine base in vapour form
11/20/2008WO2008029278A3 Conjugates of antithrombin binding oligosaccharide derivatives and therapeutic proteins
11/20/2008WO2003061577A8 Polyalkylene glycol with moiety for conjugating biologically active compound
11/20/2008US20080288627 Storage network and method for storage network device mapping
11/20/2008US20080287659 G-CSF Conjugates
11/20/2008US20080287553 Pharmaceutical compositions comprising peranhydrocyclodextrin
11/20/2008US20080287552 Process for Obtaining an Active Ingredient for Enhancing Cutaneous Mechanical Strength, Active Ingredient and Compositions
11/20/2008US20080287551 Carotenoid formulation
11/20/2008US20080287543 Pharmaceutical composition comprising 5-methyl-2 (2'-chloro-6'-fluoroanillino) phen ylacetic acid
11/20/2008US20080287524 Method of Purifying a Surfactant by Ultrafiltration
11/20/2008US20080287502 Transdermal Administration of Proton Pump Inhibitors
11/20/2008US20080287470 Presentation of an Antiviral Pharmaceutical Composition
11/20/2008US20080287464 Depot Formulations
11/20/2008US20080287456 Oral Therapeutic Compound Delivery System
11/20/2008US20080287417 Pharmaceutical compositions comprising a poorly water-soluble active ingredient, a surfactant and a water-soluble polymer
11/20/2008US20080287366 Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus
11/20/2008US20080287357 Conjugate Comprising P21 Protein for the Treatment of Cancer
11/20/2008US20080286799 Methods of and kits and compositions for diagnosing colorectal tumors...
11/20/2008US20080286368 administered sublingually in combination with a bio/mucoadhesion promoting compound (e.g. hydroxypropyl cellulose) in a manner giving rise to pharmacologically effective plasma levels of zolpidam, morphine, sufentanyl etc.within a short time after administration to treat pain, insomnia, diabetes etc
11/20/2008US20080286365 Method For Producing Solid-Lipid Composite Drug Particles
11/20/2008US20080286364 External dermatologic preparation
11/20/2008US20080286356 Pharmaceutical compositions containing terbinafin and use thereof
11/20/2008US20080286347 Bioabsorbable synthetic nonwoven fabric holding thrombin
11/20/2008US20080286323 Human Therapeutic Cells Secreting Nerve Growth Factor
11/20/2008US20080286321 Polymer No Donor Predrug Nanofiber Coating for Medical Devices and Therapy
11/20/2008US20080286316 Lipid raft, caveolin protein, and caveolar function modulation compounds and associated synthetic and therapeutic methods
11/20/2008US20080286284 Compositions of PSMA antibodies
11/20/2008US20080286280 Stable Lyophilized Pharmaceutical Preparations of Monoclonal or polyclonal antibodies
11/20/2008US20080286270 Stabilized liquid anti-RSV antibody formulations
11/20/2008US20080286262 Photosensitizers for Photodynamic Therapy at Infrared Excitation
11/20/2008US20080286255 Treatment for eye disorder
11/20/2008US20080286253 Composition Comprising Polymeric Material And Uses Thereof
11/20/2008US20080286206 Composition and Method for Medical Imaging of Body Cavities
11/20/2008US20080286205 Method for Treating Prostate Diseases Based on Local Delivery of Active Substances
11/20/2008US20080286198 Novel anti-IGF-IR antibodies and uses thereof
11/20/2008DE102005059420B4 Verwendung einer Hypromellose enthaltende zu einer Buccaltablette gepressten Haftpaste zur Behandlung lokaler Erkrankungen der Mundschleimhaut Using a Hypromellose containing compressed to a buccal adhesive paste for treatment of local diseases of the oral mucosa
11/20/2008CA2687403A1 Carbohydrate-containing pan cancer marker
11/20/2008CA2686765A1 Aqueous pharmaceutical composition
11/20/2008CA2686068A1 Biodegradable peptide releasing polymers
11/20/2008CA2685553A1 Peptide imaging agents
11/20/2008CA2685516A1 Petrolatums having silicone-like properties
11/20/2008CA2685456A1 Coated oral nicotine formulation buffered with amino acid
11/20/2008CA2685452A1 Oral nicotine formulation buffered with amino acid
11/20/2008CA2685054A1 Agent for treatment of pulmonary disease
11/20/2008CA2683590A1 Compositions that include a hydrophobic compound and a polyamino acid conjugate
11/20/2008CA2673133A1 Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof
11/20/2008CA2670694A1 Soft gel formulations
11/19/2008EP1992643A2 Compositions and methods for the diagnosis and treatment of tumor
11/19/2008EP1992364A1 Carboxylated polysaccharides phosphated or bisphosphonated derivatives, optionally cross-linked, and their preparation and biomedical uses
11/19/2008EP1992363A1 Transdermal absorption preparation
11/19/2008EP1992362A2 Preserved compositions containing hyaluronic acid or a pharmaceutically-acceptable salt thereof and related methods
11/19/2008EP1992360A1 Joint use of tgf-beta signal inhibitor and antitumor agent
11/19/2008EP1992343A1 Composition comprising a cholesterol absorption inhibitor, an HMG-CoA reductase inhibitor and a stabilizing agent
11/19/2008EP1992342A1 Minimizing adverse experience associated with oxybutynin therapy
11/19/2008EP1992340A1 Improved ophthalmic and contact lens solution
11/19/2008EP1992339A1 Use of a magnesium isotope for treating hypoxia and a medicament comprising the same
11/19/2008EP1992338A2 Pharmaceutical compositions for the oral administration of heparin or derivatives thereof
11/19/2008EP1992337A1 Novel modified release composition and use
11/19/2008EP1992335A1 Spray drying methods and compositions thereof
11/19/2008EP1992334A1 Storage-stable formulation of oxidation-sensitive phenolic drug, especially paracetamol, comprises aqueous drug solution deoxygenated by a temperature-controlled manufacturing process of the formulation
11/19/2008EP1991673A2 Method and apparatus for acne treatment using low intensity light therapy
11/19/2008EP1991589A1 Method for enhancing cyclodextrin complexation
11/19/2008EP1991586A1 Chimeric constructs between cancer-homing peptides and cell-penetrating peptides coupled to anticancer drugs and/or diagnostic agent/agents
11/19/2008EP1991277A2 Delivery of biologically active materials using core-shell tecto (dendritic polymers)
11/19/2008EP1991272A2 Antithrombotic compound
11/19/2008EP1991271A2 Anticoagulant antithrombotic dual inhibitors comprising a biotin label
11/19/2008EP1991248A2 Antidepressant prodrugs
11/19/2008EP1991240A2 Antimicrobial releasing polymers
11/19/2008EP1991239A1 Doxorubicin formulations for anti-cancer use
11/19/2008EP1991236A2 Methods of increasing oral bioavailability of tetracyclines
11/19/2008EP1991200A2 Fluoroquinolone compositions
11/19/2008EP1809264A4 Antimicrobial amorphous compositions
11/19/2008EP1638601B1 Carrier proteins for vaccines
11/19/2008EP1613288B1 Solid pharmaceutical compositions comprising a s1p receptor agonist and a sugar alcohol
11/19/2008EP1428537B1 Stabilized preparations containing antibody
11/19/2008EP1377667B1 Fusion proteins for specific treatment of cancer and auto-immune diseases
1 ... 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 ... 1712